Analyst Recommendations
Needham analyst issues BUY recommendation for FRSH on May 20, 2024 07:30AM ET. The previous analyst recommendation was Buy.FRSH was trading at $13.64 at issue of the analyst...May 20, 2024 FRSH 1.74%
Citigroup analyst issues BUY recommendation for RBRK on May 20, 2024 07:22AM ET. RBRK was trading at $36.57 at issue of the analyst recommendation.The overall analyst consensus :...May 20, 2024 RBRK 4.39%
Benchmark analyst issues BUY recommendation for QIPT on May 20, 2024 06:53AM ET. The previous analyst recommendation was Buy.QIPT was trading at $3.15 at issue of the analyst...May 20, 2024 QIPT 0.28%
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for GDEV on May 20, 2024 05:32AM ET. GDEV was trading at $2.22 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10...May 20, 2024 GDEV 0.97%
Barclays analyst issues EQUAL-WEIGHT recommendation for ADI on May 20, 2024 05:40AM ET. The previous analyst recommendation was Equal-Weight.ADI was trading at $214.08 at issue of the analyst...May 20, 2024 ADI 1.48%
Barclays analyst issues EQUAL-WEIGHT recommendation for TXN on May 20, 2024 05:41AM ET. The previous analyst recommendation was Equal-Weight.TXN was trading at $195.02 at issue of the analyst...May 20, 2024 TXN 1.21%
Barclays analyst issues EQUAL-WEIGHT recommendation for RSKD on May 20, 2024 05:49AM ET. The previous analyst recommendation was Equal-Weight.RSKD was trading at $5.97 at issue of the analyst...May 20, 2024 RSKD 3.83%
Barclays analyst issues OVERWEIGHT recommendation for NVDA on May 20, 2024 05:44AM ET. The previous analyst recommendation was Overweight.NVDA was trading at $924.79 at issue of the analyst...May 20, 2024 NVDA 1.98%
Barclays analyst issues OVERWEIGHT recommendation for ZS on May 20, 2024 05:42AM ET. The previous analyst recommendation was Overweight.ZS was trading at $178.86 at issue of the analyst...May 20, 2024 ZS 2.10%
Barclays analyst issues OVERWEIGHT recommendation for EXR on May 20, 2024 05:49AM ET. The previous analyst recommendation was Overweight.EXR was trading at $151.89 at issue of the analyst...May 20, 2024 EXR -0.71%